Clinical Trials Us
-
{
- All
- News
- Videos
-
Higher-Dose Wegovy Gets US Nod, Trials Show Over 20% Average Weight Loss, Says Drugmaker
Novo Nordisk said it plans to launch the new formulation, (semaglutide 7.2 mg), in the United States in April 2026.
-
Instagram Denies Addiction Claims In Landmark US Trial
Instagram CEO Adam Mosseri on Wednesday rejected the notion that users could be clinically addicted to social media, as he testified in a landmark California trial over whether his company knowingly hooked children on its platform for profit.
-
Pig Organ Transplants May One Day Outperform Human Donors, Says Leading Surgeon
A US clinical trial using gene-edited pig kidneys has begun, with experts saying xenotransplantation could one day offer safer and more effective alternatives to human donor organs.
-
New Nipah Vaccine Proves Safe, Triggers Antibodies In Phase 1 Results: Lancet Study
A phase 1 randomised clinical trial of a novel Nipah virus vaccine, led by US researchers, may soon pave the way to prevent the deadly infection.
-
Viagra Alternative For Women Launched In US, Works In 10 Minutes
US-based Dare Bioscience developed a topical cream with sildenafil that boosts female arousal and works in ten minutes.
-
US Aid Cuts Halt HIV Vaccine Research In South Africa, With Global Impact
Just a week had remained before scientists in South Africa were to begin clinical trials of an HIV vaccine, and hopes were high for another step toward limiting one of history's deadliest pandemics. Then the email arrived.
-
Can Artificial Intelligence Chatbots Really Improve Mental Health
Recently, I found myself pouring my heart out, not to a human, but to a chatbot named Wysa on my phone. It nodded - virtually - asked me how I was feeling and gently suggested trying breathing exercises.
-
Revolutionary New Drug Offers 99.9% Protection Against HIV
The US FDA has approved lenacapavir, a groundbreaking long-acting HIV prevention drug that offers near-complete protection with just two injections per year. Despite its potential, concerns about high costs may limit its global impact.
-
Obesity Injections May Have Fewer Weight Loss Effects In Real World: Study
Anti-obesity injections may have smaller effects on weight loss in a real-world context compared to clinical trials, as patients tend to discontinue treatment or use a lower maintenance dose, a study in US patients has found.
-
US Woman With Stage 4, 'Incurable' Colon Cancer Saved By Breakthrough Treatment
Diagnosed with Stage 4 colon cancer, Ms Dimery underwent chemotherapy, radiation and other combination therapies -- none of which seemingly worked.
-
Study Finds Severe Covid Response Could Help Shrink Tumors
A groundbreaking study suggests severe COVID infections may generate special immune cells capable of shrinking advanced cancers in mice, opening doors to innovative cancer treatments.
-
Vaccine Trial Patient In US Sues AstraZeneca, Claiming She Was Left "Permanently Disabled"
An American woman who claims she was "permanently disabled" after taking part in the US clinical trial of AstraZeneca's COVID-19 vaccine is suing the drug maker because they failed to provide her with medical care for her side effects.
-
Opinion: Would You Let Elon Musk Implant A Device In Your Brain?
Elon Musk's Neuralink received approval last week from the US Food and Drug Administration to conduct human clinical trials, which one former FDA official called "really a big deal."
-
Elon Musk's Neuralink Says It Has FDA Approval for Study of Brain Implants in Humans
Elon Musk's brain-implant company Neuralink on Thursday said the US Food and Drug Administration (FDA) had given the green light to its first-in-human clinical trial, a critical milestone after earlier struggles to gain approval.
-
Neuralink Said to Approach US Neurosurgery Centre as Potential Human Clinical Trials Partner
Neuralink, Elon Musk's brain implant company, is said to have approached one of the biggest US neurosurgery centres ahead of the company's plans to launch a human clinical trial for its devices that have been in development since 2016. The firm is working to address concerns expressed by the US Food and Drug Administration after it rejected an appl...
-
Higher-Dose Wegovy Gets US Nod, Trials Show Over 20% Average Weight Loss, Says Drugmaker
Novo Nordisk said it plans to launch the new formulation, (semaglutide 7.2 mg), in the United States in April 2026.
-
Instagram Denies Addiction Claims In Landmark US Trial
Instagram CEO Adam Mosseri on Wednesday rejected the notion that users could be clinically addicted to social media, as he testified in a landmark California trial over whether his company knowingly hooked children on its platform for profit.
-
Pig Organ Transplants May One Day Outperform Human Donors, Says Leading Surgeon
A US clinical trial using gene-edited pig kidneys has begun, with experts saying xenotransplantation could one day offer safer and more effective alternatives to human donor organs.
-
New Nipah Vaccine Proves Safe, Triggers Antibodies In Phase 1 Results: Lancet Study
A phase 1 randomised clinical trial of a novel Nipah virus vaccine, led by US researchers, may soon pave the way to prevent the deadly infection.
-
Viagra Alternative For Women Launched In US, Works In 10 Minutes
US-based Dare Bioscience developed a topical cream with sildenafil that boosts female arousal and works in ten minutes.
-
US Aid Cuts Halt HIV Vaccine Research In South Africa, With Global Impact
Just a week had remained before scientists in South Africa were to begin clinical trials of an HIV vaccine, and hopes were high for another step toward limiting one of history's deadliest pandemics. Then the email arrived.
-
Can Artificial Intelligence Chatbots Really Improve Mental Health
Recently, I found myself pouring my heart out, not to a human, but to a chatbot named Wysa on my phone. It nodded - virtually - asked me how I was feeling and gently suggested trying breathing exercises.
-
Revolutionary New Drug Offers 99.9% Protection Against HIV
The US FDA has approved lenacapavir, a groundbreaking long-acting HIV prevention drug that offers near-complete protection with just two injections per year. Despite its potential, concerns about high costs may limit its global impact.
-
Obesity Injections May Have Fewer Weight Loss Effects In Real World: Study
Anti-obesity injections may have smaller effects on weight loss in a real-world context compared to clinical trials, as patients tend to discontinue treatment or use a lower maintenance dose, a study in US patients has found.
-
US Woman With Stage 4, 'Incurable' Colon Cancer Saved By Breakthrough Treatment
Diagnosed with Stage 4 colon cancer, Ms Dimery underwent chemotherapy, radiation and other combination therapies -- none of which seemingly worked.
-
Study Finds Severe Covid Response Could Help Shrink Tumors
A groundbreaking study suggests severe COVID infections may generate special immune cells capable of shrinking advanced cancers in mice, opening doors to innovative cancer treatments.
-
Vaccine Trial Patient In US Sues AstraZeneca, Claiming She Was Left "Permanently Disabled"
An American woman who claims she was "permanently disabled" after taking part in the US clinical trial of AstraZeneca's COVID-19 vaccine is suing the drug maker because they failed to provide her with medical care for her side effects.
-
Opinion: Would You Let Elon Musk Implant A Device In Your Brain?
Elon Musk's Neuralink received approval last week from the US Food and Drug Administration to conduct human clinical trials, which one former FDA official called "really a big deal."
-
Elon Musk's Neuralink Says It Has FDA Approval for Study of Brain Implants in Humans
Elon Musk's brain-implant company Neuralink on Thursday said the US Food and Drug Administration (FDA) had given the green light to its first-in-human clinical trial, a critical milestone after earlier struggles to gain approval.
-
Neuralink Said to Approach US Neurosurgery Centre as Potential Human Clinical Trials Partner
Neuralink, Elon Musk's brain implant company, is said to have approached one of the biggest US neurosurgery centres ahead of the company's plans to launch a human clinical trial for its devices that have been in development since 2016. The firm is working to address concerns expressed by the US Food and Drug Administration after it rejected an appl...
